0001209191-20-008895.txt : 20200212 0001209191-20-008895.hdr.sgml : 20200212 20200212172432 ACCESSION NUMBER: 0001209191-20-008895 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200210 FILED AS OF DATE: 20200212 DATE AS OF CHANGE: 20200212 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Silva Paul M CENTRAL INDEX KEY: 0001446372 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 20605629 MAIL ADDRESS: STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED STREET 2: 130 WAVERLY ST CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-02-10 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001446372 Silva Paul M C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 0 1 0 0 SVP & Controller Common Stock 2020-02-10 4 F 0 4673 240.95 D 25550 D Common Stock 2020-02-11 4 S 0 380 243.59 D 25170 D Common Stock 2020-02-11 4 S 0 1560 244.90 D 23610 D Common Stock 2020-02-11 4 S 0 1700 245.89 D 21910 D Common Stock 2020-02-11 4 S 0 1120 246.84 D 20790 D Common Stock 2020-02-11 4 S 0 1102 247.93 D 19688 D Common Stock 169 I 401(k) Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $243.59 (range $243.29 to $244.28). Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $244.90 (range $244.37 to $245.33). Open market sales reported on this line occurred at a weighted average price of $245.89 (range $245.39 to $246.30). Open market sales reported on this line occurred at a weighted average price of $246.84 (range $246.46 to $247.38). Open market sales reported on this line occurred at a weighted average price of $247.93 (range $247.58 to $248.55). /s/ Omar White, Attorney-in-Fact 2020-02-12